Ljubljana – Novartis has signed an initial agreement to use its manufacturing facility in Ljubljana to fill the Pfizer-BioNTech vaccine against Covid-19. The Novartis Technical Operations site in Ljubljana will fill at least 24 million doses in its sterile manufacturing facilities in 2022, the Swiss pharma company announced on Thursday. Novartis plans to take bulk mRNA active ingredient from BioNTech and fill it into vials under sterile conditions for shipment back to BioNTech for its distribution. Subject to reaching a final agreement, Novartis plans to start filling and finishing the…
